Generate Biomedicines, Inc.

Direct answer

Generate Biomedicines, Inc. is publicly traded on NASDAQ under the ticker GENB.

Generate Biomedicines, Inc. is a U.S.-based company pioneering generative biology, leveraging machine learning for the discovery and advancement of novel protein therapeutics. Their core approach involves developing drugs using protein-based modalities. The company's pipeline includes several key candidates: GB-0895, an investigational long-acting anti-TSLP monoclonal antibody designed for bi-annual dosing in severe...

Can you invest in Generate Biomedicines, Inc.?

Yes. Generate Biomedicines, Inc. trades publicly on NASDAQ as GENB.

View deeper analysis

View detailed research on MarketSnap, including financials, valuation tools, and analyst context.

Open research for Generate Biomedicines, Inc.

Detailed equity research is provided by MarketSnap.